Search

Your search keyword '"Skowasch, Dirk"' showing total 758 results

Search Constraints

Start Over You searched for: Author "Skowasch, Dirk" Remove constraint Author: "Skowasch, Dirk"
758 results on '"Skowasch, Dirk"'

Search Results

3. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry

4. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

5. Autorinnen und Autoren

8. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era

13. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

18. Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease

19. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

20. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

21. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

22. German asthma net: Nasal polyposis in patients in the severe asthma registry

23. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

28. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

32. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

33. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

34. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

36. Early-stage idiopathic pulmonary fibrosis is characterized by bronchoalveolar accumulation of SPP1+macrophages

37. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?

38. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen

40. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany

41. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

42. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

47. Response to biologics and clinical remission in the adult GAN severe asthma cohort.

48. German Asthma Net: Nasal polyposis in patients with severe asthma

49. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry

Catalog

Books, media, physical & digital resources